An Open-Label Study of an Ophthalmic Solution to Reduce Intraocular Pressure in Patients With Ocular Hypertension

Chakshu Research

Status: Completed

Conditions: Ocular Hypertension

Treatments: Drug: C-KAD Ophthalmic Solution

Study type: Interventional

Funder types: Industry

Identifiers

NCT00825396

PCK-0106

Details and patient eligibility

About

The purpose of this study is to determine the safety and tolerability of topical C-KAD Ophthalmic Solution in reducing intraocular pressure in patients with ocular hypertension.

Enrollment: 12 estimated patients

Sex: All

Ages: 50 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Both eyes having intraocular pressure in the range of 22-30 mmHg at baseline
• Both eyes having best corrected visual acuity better than 20/50

Exclusion criteria

• Advanced glaucoma
• Closed or barely open anterior chamber or history of angle closure

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

12 participants in 1 patient group

C-KAD Ophthalmic Solution

Experimental group

Treatment:

Drug: C-KAD Ophthalmic Solution